课题基金 / 基金详情

项目摘要

项目成果

Stephen Jay Freedland的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Diet is thought to play a major role in prostate cancer development and progression, yet little is currently known. Preliminary studies from our laboratory have demonstrated that a diet completely devoid of carbohydrates can slow in vivo prostate cancer growth and appears to act via the insulin-like growth factor (IGF) axis. Recent data from others suggests that resveratrol, a natural phytochemical found in red wine, can slow tumor growth via the same mechanism. We hypothesize that the combination of carbohydrate restriction plus resveratrol , both acting via IGF-axis inhibition, can a ct together to delay prostate cancer growth. To test this hypothesis, we will pursue the following course of study: 1) determine the amount of carbohydrate restriction needed to maximally delay prostate cancer growth; 2) eucidate the role of resveratrol in delaying prostate cancer growth and determine the dose which maximally delays tumor growth; and 3) explore the combined effects of carbohydrate restriction and resveratrol supplementation relative to treatment with a Western diet. We believe these studies will better elucidate the role of carbohydrate restriction and resveratrol in modulating in vivo prostate cancer growth and will lay the solid foundation for future preclinical studies for men with prostate cancer. PUBLIC HEALTH STATEMENT Prostate cancer is a major cause of morbidity and mortality among men in the United States. In this proposal, we aim to develop novel non-toxic complementary treatments aimed at slowing prostate cancer progression: dietary modification and phytopharmaceuticals. If these pre-clinical studies are successful, this will lay a solid foundation for future clinical studies among men with prostate cancer, which eventually stand the possibility of radically altering and improving care for men with prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment
  • 批准号:
    10568656
  • 项目类别:
  • 资助金额:
    $73.91万
  • 财政年份:
    2023
  • 负责人:
    Stephen Jay Freedland
  • 依托单位:
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology
Racial Differences in Prostate Cancer Molecular Subtyping
  • 批准号:
    10381279
  • 项目类别:
  • 资助金额:
    $8.5万
  • 财政年份:
    2021
  • 负责人:
    Stephen Jay Freedland
  • 依托单位:
Racial Differences in Prostate Cancer Molecular Subtyping
  • 批准号:
    9889065
  • 项目类别:
  • 资助金额:
    $55.03万
  • 财政年份:
    2018
  • 负责人:
    Stephen Jay Freedland
  • 依托单位:
海外基金